Monthly Webinar Series
September 2019
Monthly Webinar Series September 2019 Todays Agenda Announcements - - PowerPoint PPT Presentation
Monthly Webinar Series September 2019 Todays Agenda Announcements & Trial Updates Sandi Cassard Monthly Randomization Race Amanda Bistran-Hall Recently Asked Questions about Biobanking Susan Emrich Q&A All Announcements &
September 2019
Announcements & Trial Updates Sandi Cassard Monthly Randomization Race Amanda Bistran-Hall Recently Asked Questions about Biobanking Susan Emrich Q&A All
SANDI CASSARD
THANK YOU for continuing to screen and enroll patients! We have 46 sites activated and 287 patients enrolled as of 09/04/19! We hope that you are all refreshed from your summer vacations and the holiday weekend and have renewed energy for the trial! Please find at least 1 new candidate each week so we can accelerate enrollment!!!
1) We will be amending subcontracts for the main study this fall, adding payments to the study budget for EDSS exams at the month 18, 30 and 42 visits. 2) Biobanking subcontracts are in process and we will pay for all blood draws that have been done at each participating site as soon as the subcontract is fully executed and PO is assigned. Susan Emrich, biobanking manager, will help your site generate the invoice to be paid. THANK YOU for continuing to enroll and draw samples for the biobanking substudy!
Please visit the study website: http://treat-mstrial.org to download case report forms (CRFs) for your upcoming month 18 and month 24 visits.
Next SAC Conference Call Friday, September 27, 2019 1:00 – 2:00 pm EDT
Next in-person SAC Meeting Wednesday, February 26, 2020 1:30 – 5:00 pm EST Hilton West Palm Beach, Florida (preceding ACTRIMS meeting)
AMANDA BISTRAN-HALL
August’s Top Performers:
Site Randomizations
Johns Hopkins Hospital 5 University of South Florida 3 University of California at Los Angeles 2 Swedish Health Services 2 Cedars Sinai Medical Center 2
2 Baylor Research Institute 2
August’s Top Enroller:
University of South Florida
$50
SUSAN EMRICH
1) Timing and labeling Baseline and Month 6 samples 2) Blood draws at Subsequent Visits 3) Shipping Ambient Samples to UAB 4) Vision Database Entries
Question: If a patient consents to the biobanking substudy but no sample was drawn at the Baseline visit, can samples be collected at a future visit? How should the visit be labeled on the tubes and in VISION? Answer: Yes! If the patient returns for an interim visit (e.g., month 3 clinic visit or infusion visit), the sample should be collected and labeled as a Baseline visit sample. It is appropriate to label it as a Baseline visit sample, even if the patient has already started on a DMT.
Question: If a patient did not initially consent to biobanking and has started a DMT, can they still join the substudy at a later time? Answer: Absolutely! A patient can consent to participate at any time during the main TREAT-MS trial. Once consented, please draw blood at the earliest opportunity. If the patient has been enrolled in the study for less than 6 months, label the visit/samples as Baseline. If it has been greater than or equal to 6 months, but less than 1 year after enrollment, label the visit/samples as Month 6.
Question: Please clarify the timing of the Month 6 blood draw? Answer: The Month 6 blood draw should be included as part of the routine Month 6 clinic visit and is not dependent on DMT start date.
Question: In addition to the Baseline and Month 6 blood draws should we draw again at the Month 12 visit? Answer: Additional blood draws should only occur if there is a switch in DMT due to breakthrough disease. The additional draw should occur at the time of DMT switch (at the visit when a decision is made to change DMT) and again six months after being on the second DMT.
Question: If a patient consents to the biobanking substudy, what do I enter in the VISION database? Answer:
Question: Will you please review what information goes in the shipper to UAB? Answer: For each participant visit requiring a blood draw, the coordinator will prepare a specimen transport bag containing the needed blood collection tubes, labeled with the TREAT-MS ID (XXXX- YYY), visit date (DDMMMYY – eg: 05SEP18) and type of visit (BL, M6, SX, or ES). Coordinators will also complete a Biobanking Specimen Card that will be included with the shipment. A copy of the completed card should be made and stored with the patient’s CRFs.
Shipments should be sent on Monday – Thursday only. No Friday shipments should be sent. Call FedEx (1-800-463-3339) to arrange same day pickup.
Question: What information should be entered into Vision database when a sample is collected? Answer:
Source Docs in Vision EDC
S3-next switch of DMT (if applicable), S4-6 months after start of 3rd DMT (if applicable), and ES- end of study)
The October Monthly Webinar will be held on the 2nd at 3 PM and 3rd at 9 AM EDT